Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
May 4, 2021
Patent Application Number
16505074
Date Filed
July 8, 2019
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention provides methods and compositions for inhibiting atherosclerotic plaque formation in a subject. In certain embodiments, the methods of the present invention comprise selecting a subject who has, or is at risk of developing, atherosclerosis, and administering to the subject a pharmaceutical composition comprising a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor. In certain embodiments, the PCSK9 inhibitor is an anti-PCSK9 antibody, or antigen binding protein.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
